In-silico Design of a Core Scaffold Pyrazolone Fused Heterocyclic Analogues as Dual Inhibitors Targeting Breast Cancer. Asian Journal of Pharmaceutical and Health Sciences, [S. l.], v. 11, n. 2, p. 2468–2474, 2021. DOI: 10.5530/qsrddd17. Disponível em: https://ajphs.com/index.php/ajphs/article/view/126. Acesso em: 15 oct. 2025.